Mettler-Toledo (MTD) Stock Forecast & Price Target

Compare

512 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MTD Analyst Ratings

Moderate Buy

4 Buy

5 Hold

0 Sell

Based on 9 analysts giving stock ratings to

Mettler-Toledo

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MTD Stock 12 Month Forecast

Average Price Target

$1,486.86

▲(9.25% Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Mettler-Toledo in the last 3 months. The average price target is $1,486.86 with a high forecast of $1,600.00 and a low forecast of $1,413.00. The average price target represents a 9.25% change from the last price of $1,360.95.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1055":"$1,055","1328":"$1,328","1601":"$1,601","1191.5":"$1,191.5","1464.5":"$1,464.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1600,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.60K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1486.86,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.49K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1413,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.41K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1055,1191.5,1328,1464.5,1601],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1385.61,1402.1015384615384,1418.5930769230768,1435.0846153846153,1451.5761538461538,1468.0676923076921,1484.5592307692307,1501.0507692307692,1517.5423076923075,1534.033846153846,1550.5253846153846,1567.016923076923,1583.5084615384615,{"y":1600,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1385.61,1393.3984615384613,1401.186923076923,1408.9753846153844,1416.763846153846,1424.5523076923075,1432.3407692307692,1440.1292307692306,1447.9176923076923,1455.7061538461537,1463.4946153846154,1471.2830769230768,1479.0715384615382,{"y":1486.86,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1385.61,1387.716923076923,1389.823846153846,1391.930769230769,1394.0376923076922,1396.1446153846152,1398.2515384615383,1400.3584615384616,1402.4653846153847,1404.5723076923077,1406.6792307692308,1408.7861538461539,1410.893076923077,{"y":1413,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1364.44,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1272.72,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1156.38,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1056.58,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1141.13,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1205.29,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1197.23,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1276,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1289.82,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1416.29,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1468.09,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1394.19,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1385.61,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,600

Average Price Target$1,487

Lowest Price Target$1,413

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Kallum Titchmarsh

Morgan Stanley

$1,550→$1,475

Hold

8.38%

Upside

Reiterated

02/10/26

Analysts Conflicted on These Healthcare Names: Mettler-Toledo (NYSE: MTD), Nuvation Bio (NYSE: NUVB) and Mereo Biopharma Group Plc (NASDAQ: MREO)

Catherine Ramsey Schulte

Robert W. Baird

$1,444→$1,445

Hold

6.18%

Upside

Reiterated

02/09/26

Mettler-Toledo price target raised to $1,445 from $1,444 at BairdMettler-Toledo price target raised to $1,445 from $1,444 at Baird

Casey Woodring

J.P. Morgan

$1,413

Hold

3.82%

Upside

Reiterated

02/09/26

Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), Phibro Animal Health (NASDAQ: PAHC) and Siemens Healthineers AG (Other OTC: SEMHF)

Michael Ryskin

Bank of America Securities

Buy

―

Reiterated

02/06/26

Analysts' Top Healthcare Picks: Mettler-Toledo (MTD), Abbott Laboratories (ABT)

Daniel Arias

Stifel Nicolaus

$1,600

Buy

17.56%

Upside

Reiterated

02/06/26

Stifel Nicolaus Keeps Their Buy Rating on Mettler-Toledo (MTD)

Luke Sergott

Barclays

$1,550

Buy

13.89%

Upside

Reiterated

02/06/26

Barclays Sticks to Its Buy Rating for Mettler-Toledo (MTD)

Patrick B Donnelly

Citi

$1,700→

Buy

―

Reiterated

01/02/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Brandon Couillard

Wells Fargo

$1,400→$1,450

Hold

6.54%

Upside

Reiterated

12/15/25

Mettler-Toledo price target raised to $1,450 from $1,400 at Wells FargoMettler-Toledo price target raised to $1,450 from $1,400 at Wells Fargo

Evie Koslosky

Goldman Sachs

$1,475

Hold

8.38%

Upside

Initiated

12/09/25

Mettler-Toledo initiated with a Neutral at Goldman SachsMettler-Toledo initiated with a Neutral at Goldman Sachs

Vijay Kumar

Evercore ISI

$1,275→$1,400

Buy

2.87%

Upside

Reiterated

10/07/25

Evercore ups Mettler-Toledo price target, adds to 'Tactical Underperform' listEvercore ups Mettler-Toledo price target, adds to 'Tactical Underperform' list

Tycho Peterson

Jefferies

$1,110→$1,150

Hold

-15.50%

Downside

Reiterated

08/01/25

Mettler-Toledo price target raised to $1,150 from $1,100 at JefferiesMettler-Toledo price target raised to $1,150 from $1,100 at Jefferies

Dan Leonard

UBS

$1,530→$1,350

Buy

-0.80%

Downside

Upgraded

05/19/25

Mettler-Toledo upgraded at UBS on tailwinds from reshoring, pricing powerUBS upgraded the U.S. life sciences company to Buy from Neutral, citing benefits from biopharmas recent reshoring efforts and the companys pricing power.

Unknown Analyst

CFRA

Not Ranked

CFRA

$1,045

Hold

-23.22%

Downside

Upgraded

04/07/25

CFRA upgrades Mettler-Toledo (MTD) to HoldCFRA upgraded Mettler-Toledo (NYSE: MTD) from Sell to Hold with a price target of $1,045.00.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Kallum Titchmarsh

Morgan Stanley

$1,550→$1,475

Hold

8.38%

Upside

Reiterated

02/10/26

Analysts Conflicted on These Healthcare Names: Mettler-Toledo (NYSE: MTD), Nuvation Bio (NYSE: NUVB) and Mereo Biopharma Group Plc (NASDAQ: MREO)

Catherine Ramsey Schulte

Robert W. Baird

$1,444→$1,445

Hold

6.18%

Upside

Reiterated

02/09/26

Mettler-Toledo price target raised to $1,445 from $1,444 at BairdMettler-Toledo price target raised to $1,445 from $1,444 at Baird

Casey Woodring

J.P. Morgan

$1,413

Hold

3.82%

Upside

Reiterated

02/09/26

Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), Phibro Animal Health (NASDAQ: PAHC) and Siemens Healthineers AG (Other OTC: SEMHF)

Michael Ryskin

Bank of America Securities

Buy

―

Reiterated

02/06/26

Analysts' Top Healthcare Picks: Mettler-Toledo (MTD), Abbott Laboratories (ABT)

Daniel Arias

Stifel Nicolaus

$1,600

Buy

17.56%

Upside

Reiterated

02/06/26

Stifel Nicolaus Keeps Their Buy Rating on Mettler-Toledo (MTD)

Luke Sergott

Barclays

$1,550

Buy

13.89%

Upside

Reiterated

02/06/26

Barclays Sticks to Its Buy Rating for Mettler-Toledo (MTD)

Patrick B Donnelly

Citi

$1,700→

Buy

―

Reiterated

01/02/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Brandon Couillard

Wells Fargo

$1,400→$1,450

Hold

6.54%

Upside

Reiterated

12/15/25

Mettler-Toledo price target raised to $1,450 from $1,400 at Wells FargoMettler-Toledo price target raised to $1,450 from $1,400 at Wells Fargo

Evie Koslosky

Goldman Sachs

$1,475

Hold

8.38%

Upside

Initiated

12/09/25

Mettler-Toledo initiated with a Neutral at Goldman SachsMettler-Toledo initiated with a Neutral at Goldman Sachs

Vijay Kumar

Evercore ISI

$1,275→$1,400

Buy

2.87%

Upside

Reiterated

10/07/25

Evercore ups Mettler-Toledo price target, adds to 'Tactical Underperform' listEvercore ups Mettler-Toledo price target, adds to 'Tactical Underperform' list

Tycho Peterson

Jefferies

$1,110→$1,150

Hold

-15.50%

Downside

Reiterated

08/01/25

Mettler-Toledo price target raised to $1,150 from $1,100 at JefferiesMettler-Toledo price target raised to $1,150 from $1,100 at Jefferies

Dan Leonard

UBS

$1,530→$1,350

Buy

-0.80%

Downside

Upgraded

05/19/25

Unknown Analyst

CFRA

Not Ranked

CFRA

$1,045

Hold

-23.22%

Downside

Upgraded

04/07/25

CFRA upgrades Mettler-Toledo (MTD) to HoldCFRA upgraded Mettler-Toledo (NYSE: MTD) from Sell to Hold with a price target of $1,045.00.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Mettler-Toledo

3 Months

xxx

Success Rate

12/19 ratings generated profit

Average Return

+3.12%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 63.16% of your transactions generating a profit, with an average return of +3.12% per trade.

1 Year

Vijay KumarEvercore ISI

Success Rate

6/7 ratings generated profit

Average Return

+2.34%

reiterated a buy rating 4 months ago

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +2.34% per trade.

2 Years

xxx

Success Rate

6/7 ratings generated profit

Average Return

+1.99%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +1.99% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MTD Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MTD has received 7 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. MTD average Analyst price target in the past 3 months is 1,486.86.

Each month's total comprises the sum of three months' worth of ratings.

MTD Financial Forecast

MTD Earnings Forecast

Next quarter’s earnings estimate for MTD is $8.70 with a range of $8.62 to $8.80. The previous quarter’s EPS was $13.36. MTD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year MTD has Performed in-line its overall industry.

MTD Sales Forecast

Next quarter’s sales forecast for MTD is $941.97M with a range of $922.36M to $951.00M. The previous quarter’s sales results were $1.13B. MTD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year MTD has Performed in-line its overall industry.

MTD Stock Forecast FAQ

What is MTD’s average 12-month price target, according to analysts?

Based on analyst ratings, Mettler-Toledo International’s 12-month average price target is 1,486.86.

What is MTD’s upside potential, based on the analysts’ average price target?

Mettler-Toledo International has 9.25% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MTD a Buy, Sell or Hold?

Mettler-Toledo International has a consensus rating of Moderate Buy which is based on 4 buy ratings, 5 hold ratings and 0 sell ratings.

What is Mettler-Toledo International’s price target?

The average price target for Mettler-Toledo International is 1,486.86. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,600.00 ,the lowest forecast is $1,413.00. The average price target represents 9.25% Increase from the current price of $1,360.95.

What do analysts say about Mettler-Toledo International?

Mettler-Toledo International’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of MTD?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Mettler-Toledo (MTD) Stock Forecast & Price Target

MTD Analyst Ratings

MTD Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Mettler-Toledo

MTD Analyst Recommendation Trends

MTD Financial Forecast

MTD Earnings Forecast

MTD Sales Forecast

MTD Stock Forecast FAQ

Detailed List of Analyst Forecasts